Price RB

Department of Psychiatry, University of Pittsburgh, PA, USA.

5 papers · ORCID

ArticlePsilocybin

The intersection between psychedelics and schizophrenia spectrum disorders: Reevaluating risk and therapeutic potential.

Brar PS, Price RB, Ross S +2

Europe PMC2026
ArticleKetamine

Mindfulness, music, visual occlusion in ketamine therapy for depression: do they change outcomes? A qualitative and quantitative analysis of a randomized controlled trial.

Kheirkhah M, McDonald N, Aepfelbacher J +17

Europe PMC2025
ArticleKetamine

Effects of ketamine on individual symptoms and symptom networks of depression in a randomised controlled trial of ketamine for treatment-resistant depression.

Hossein S, Rengasamy M, Uzamere A +5

Europe PMC2025
ArticleKetamine

Exploring the impact of music on response to ketamine/esketamine: A scoping review.

Kheirkhah M, Nugent AC, Livinski AA +11

Europe PMC2024
ArticleKetamine

Experiences of Awe Mediate Ketamine's Antidepressant Effects: Findings From a Randomized Controlled Trial in Treatment-Resistant Depression.

Aepfelbacher J, Panny B, Price RB

Europe PMC2024